Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) this
morning announced the successful completion of its first international cannabis
shipment from Canada into Israel. Supreme Cannabis partnered with Israel’s
largest producer of medical cannabis and cannabis products, Breath of Life
International Ltd. (“BOL Pharma”), to offer Truverra-branded premium medical
cannabis to patients in Israel. Additionally, the company provided a corporate
update regarding COVID-19, in which it detailed its efforts to mitigate risk
and manage disruption to its operations. Per the update, minor external
business disruptions including supplier and third-party testing delays have
extended the launch dates for 7ACRES’ whole flower pre-rolls and PAX pods for
the PAX Era vaporizer. They are now anticipated to launch during fiscal Q4
2020. “This transaction represents a new international revenue opportunity for
Supreme Cannabis and builds Truverra’s global medical brand in one of the most
sophisticated medical cannabis markets in the world,” Supreme Cannabis Interim
president and CEO Colin Moore stated in the news release. “With the support of
BOL Pharma, we navigated both Canada and Israel’s complex regulatory landscapes
to achieve compliance with regulatory authorities in both countries, including
Health Canada, the Canadian Food Inspection Agency and Israel’s Ministry of
Health and Ministry of Agriculture and Rural Development. We benefitted from
BOL Pharma’s skilled team, international experience and solidified position as
a leading medical cannabis company in Israel. As we pursue capital-light
international opportunities, we will continue to look to Jeff Adams, Truverra’s
CEO, and his exceptional team to build Truverra’s medical brand globally.”
To view the full press release, visit http://ibn.fm/x3Yol
About Supreme Cannabis Company Inc.
Supreme Cannabis is a global, diversified portfolio of
distinct cannabis companies, products and brands. Since 2014, the company has
emerged as one of the world’s fastest-growing, premium, plant-driven lifestyle
companies. Supreme Cannabis’ portfolio of brands caters to diverse consumer
experiences, with brands and products that address recreational, wellness,
medicinal and new-consumer preferences. The company’s brand portfolio includes
7ACRES, Blissco, Truverra, Sugarleaf by 7AC and Khalifa Kush Enterprises
Canada. Supreme Cannabis’ brands are backed by a focused suite of world-class
operating assets that serve key functions in the value chain, including scaled
cultivation, value-add processing, centralized manufacturing and product
testing, and R&D. For more information, visit the company’s website
at www.Supreme.ca.
NOTE TO INVESTORS: The latest news and updates
relating to SPRWF are available in the company’s newsroom at http://ibn.fm/SPRWF
About QualityStocksNewsBreaks
QualityStocksNewsBreaks provide
a rapid summary of corporate news that catch the attention of QualityStocks.
QualityStocksBreaks are designed to keep investors up to date on important and
breaking news in the small-cap and micro-cap markets. Spanning all industries,
including energy, entertainment, telecommunications, healthcare, retail and
more, these news breaks deliver opportunities the investment community may have
missed. Whether it is earnings results, mergers and acquisitions, or any other
market-moving news, our news breaks keep you in the know. QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment